General description
The antibody DR5-01-1 recognizes an extracellular domain of TRAIL-R2 (DR5). TRAIL-R2 is one of two TNF superfamily member intracellular death domain containing receptors for TRAIL (APO2L).
Immunogen
Recombinant fusion protein of human IgG heavy chain and extracellular domain of DR5
Application
The reagent is designed for Flow Cytometry analysis. Suggested working dilution is 5 μg/mL of sample. Indicated dilution is recommended starting point for use of this product. Working concentrations should be determined by the investigator.
Features and Benefits
Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.
Physical form
Solution in phosphate buffered saline containing 15 mM sodium azide and 0.2% high-grade protease free BSA as a stabilizing agent.
| biological source | mouse |
| Quality Segment | 100 |
| conjugate | phycoerythrin (R-PE) conjugate |
| antibody form | purified immunoglobulin |
| antibody product type | primary antibodies |
| clone | DR5-01-1, monoclonal |
| form | buffered aqueous solution |
| species reactivity | human |
| concentration | 0.1 mg/mL |
| technique(s) | flow cytometry: suitable |
| isotype | IgG1 |
| NCBI accession no. | NM_003842.4 |
| UniProt accession no. | O14763 |
| shipped in | wet ice |
| storage temp. | 2-8°C |
| target post-translational modification | unmodified |
| Gene Information | human ... TNFRSF10B(8795) |
